Gene: RWDD2B
Official Full Name: RWD domain containing 2Bprovided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32329 | RWDD2B Knockout cell line (HeLa) | Human | RWDD2B | 1:3~1:6 | Negative | Online Inquiry |
KO32330 | RWDD2B Knockout cell line (HCT 116) | Human | RWDD2B | 1:2~1:4 | Negative | Online Inquiry |
KO32331 | RWDD2B Knockout cell line (HEK293) | Human | RWDD2B | 1:3~1:6 | Negative | Online Inquiry |
KO32332 | RWDD2B Knockout cell line (A549) | Human | RWDD2B | 1:3~1:4 | Negative | Online Inquiry |
RWDD2B Gene Knockout Cell Lines are genetically engineered cellular models designed to facilitate intensive research into the functions and interactions of the RWDD2B gene. This particular gene plays a crucial role in numerous biological processes, including cellular signaling and stress response, making its study vital for understanding various disease mechanisms and therapeutic targets.
The key function of RWDD2B Gene Knockout Cell Lines is to provide a platform for investigating the phenotypic consequences of the loss of RWDD2B expression. The knockout method employs advanced CRISPR-Cas9 technology to induce precise deletions within the gene, thereby disrupting its normal function. Researchers can leverage these cell lines to elucidate the physiological roles of RWDD2B, evaluate its impact on cellular behavior, and assess potential pathways influencing diseases such as cancer, neurodegenerative disorders, or metabolic syndromes.
Scientifically, these cell lines hold immense value in both basic and translational research. They are indispensable tools for examining gene function, validating drug targets, and exploring molecular mechanisms underpinning complex cellular responses. Additionally, they can inform therapeutic strategies by identifying compensatory mechanisms activated in the absence of RWDD2B, thus paving the way for novel interventions.
What sets the RWDD2B Gene Knockout Cell Lines apart from alternative models is their rigorously validated genetic modification and the ease of use they offer to researchers. Unlike traditional knockout methods that may introduce off-target effects or require extensive validation, the CRISPR-Cas9 approach ensures specificity and reliability, thus saving valuable time and resources in experimental workflows.
For researchers and clinicians focused on gene function and disease pathway analysis, RWDD2B Gene Knockout Cell Lines represent an invaluable resource. Their incorporation into research can yield insights that facilitate groundbreaking discoveries and contribute to therapeutic advancements. Our company’s commitment to high-quality, precision-engineered biological products ensures that our customers receive reliable tools that drive their research objectives forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.